Data taken from [25,34,47,49]. Hypertension is commonly found in older (aged 60–79 years) and elderly (aged ≥80 years) people, and is an important contributor to their high absolute ...

Systolic hypertension is a major health economy problem within our aging society. Increased arterial stiffness is the vascular phenotype of systolic hypertension, especially of the large arteries.

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

Hypertension is a major cause of death in dialysis patients. Uncontrolled hypertension is an important risk factor for cardiovascular complications such as left ventricular hypertrophy (LVH) and ...

Hypertension Research is the official journal ... clinical and epidemiological studies and basic research (e.g. pathophysiology, genetics, metabolomics, pharmacology, molecular biology, and ...

The Vascular Biology and Hypertension Program focuses on molecular and cellular approaches to important problems in cardiovascular medicine. Active in clinical trials include novel therapeutic agents ...

Mendelian randomization (MR) represents a valuable methodology to address the causal relationships between an exposure and an outcome. In MR studies, instrumental variables associated with the ...

TRYVIO (aprocitentan) in the US and JERAYGO in Europe present significant market potential as novel therapies for patients with hypertension ...

The Connection Between OSA and Hypertension OSA has been strongly ... concentrations. The pathophysiology of OSA-associated dyslipidemia involves CIH-driven alterations in lipid metabolism ...